<qa>  What type of treatment did participants with more than 3 previous chemotherapy regimens for metastatic disease and- Participants with more than 3 previous chemotherapy regimens for metastatic disease and known hypersensitivity to components of trabectedin intravenous formulation or dexamethasone 